STRENGTHING CLINICAL TRIALS FOR CANADIANS
RENFORCEMENT DES ESSAIS CLINIQUES POUR LES CANADIENS
About
Executive Committee
National Advisory Group
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
Patient Registries Listing
Fair Market Value Project
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
About
Executive Committee
National Advisory Group
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
Patient Registries Listing
Fair Market Value Project
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
Latest News
BC AHSN to integrate clinical research support function under Clinical Trials BC
Admin123
June 20, 2017
Latest News
BC AHSN to integrate clinical research support function under Clinical Trials BC
Latest Updates
mCTA Version 8 offered for use to everyone interested in being an early adopter
HealthCareCAN welcomes Paul-Émile Cloutier as new President and CEO
The Canadian Clinical Trials Coordinating Centre – A Unique Partnership for Promoting Canada as a Destination for Clinical Trials: Part II
About
Executive Committee
National Advisory Group
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
Patient Registries Listing
Fair Market Value Project
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
